National Jewish Health
Mimi Saavedra is an Associate Professor of Medicine at National Jewish Health in Denver, Colorado. She is a co-Director of the Colorado Adult CF Program. She has studied biomarkers of treatment response in CF for the past 20 years, incorporating systems biology approaches including genomics and metabolomics. Her research is thematically centered upon the immunologic basis for differential treatment outcomes in CF. Utilizing biospecimens from subjects with CF, her lab studies whether inflammatory gene signatures can stratify the types of inflammation associated with optimal and suboptimal treatment responses in CF. This work is the basis for several patents applying novel molecular diagnostic technologies to improving clinical predictions in CF.
RT7-IMI: Biomarker or Bumpkis? Validating Markers of Inflammation Post-ETI
Thursday, September 26, 2024
12:30 PM – 2:00 PM ET
W26.3- The relationship of the CF metabolome to treatment response following CFTR rescue
Friday, September 27, 2024
10:15 AM – 12:15 PM ET